EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, FIT Biotech Oy's enterprise value is €13.54 Mil.
FIT Biotech Oy's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 was €0.00 Mil. Therefore, FIT Biotech Oy's EV-to-Revenue for today is .
The historical rank and industry rank for FIT Biotech Oy's EV-to-Revenue or its related term are showing as below:
OHEL:FITBIO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 511 Med: 641.8 Max: 1847.9
Current: 1353.9
During the past 5 years, the highest EV-to-Revenue of FIT Biotech Oy was 1847.90. The lowest was 511.00. And the median was 641.80.
OHEL:FITBIO's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.57
vs OHEL:FITBIO: 1353.90
As of today (2024-06-19), FIT Biotech Oy's stock price is €0.00.
FIT Biotech Oy's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2018 was €0.00. Therefore, FIT Biotech Oy's PS Ratio for today is .
FIT Biotech Oy EV-to-Revenue Historical Data
The historical data trend for FIT Biotech Oy's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of FIT Biotech Oy's EV-to-Revenue
For the Biotechnology subindustry, FIT Biotech Oy's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FIT Biotech Oy's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FIT Biotech Oy's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where FIT Biotech Oy's EV-to-Revenue falls into.
FIT Biotech Oy's current Enterprise Value is €13.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FIT Biotech Oy's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FIT Biotech Oy (OHEL:FITBIO) EV-to-Revenue Explanation
FIT Biotech Oy's share price for today is €0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2018 was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FIT Biotech Oy EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of FIT Biotech Oy's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
FIT Biotech Oy is a clinical-stage biotechnology company. It is primarily focused on developing antibody therapies for cancer immunotherapy as well as Deoxyribonucleic acid (DNA) vaccines for the prevention of infectious diseases such as Human immunodeficiency virus (HIV). The firm's GTU technology enables the production of antibodies in the human body instead of using industrially manufactured antibodies. The GTU technology platform has various application areas. The group generates revenue through the sales of services related to the HIV vaccine. The organization is based in Finland.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OHEL:FITBIO has been successfully added to your 